Intestinal Research

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial

Toshifumi Hibi, Satoshi Motoya, Tadakazu Hisamatsu, Fumihito Hirai, Kenji Watanabe, Katsuyoshi Matsuoka, Masayuki Saruta, Taku Kobayashi, Brian G Feagan, Chantal Tasset, Robin Besuyen, Chohee Yun, Gerald Crans, Jie Zhang, Akira Kondo, Mamoru Watanabe

Intest Res. 2023;21(1):110-125. Published online March 11, 2022
DOI: https://doi.org/10.5217/ir.2021.00143

Intestinal Research. 2023;21(1):110-125

Link1

Link2 Link3

DOP45 Predicting late responders to filgotinib in patients with moderately to severely active Ulcerative Colitis: A post hoc analysis of SELECTION and SELECTIONLTE

K Matsuoka, M Löwenberg, M Fumery, Y Takatori, Y Fujitani, A Oortwijn, M Faes, C Jamoul, T Hibi

Journal of Crohn's and Colitis. 2023;17(Supplement_1):i112-i113

Link1

Link2

DOP37 Efficacy and safety of filgotinib in patients with Ulcerative Colitis stratified by age: Post hoc analysis of the phase 2b/3 SELECTION and SELECTIONLTE studies

S Schreiber, E V Loftus, C Maaser, S Danese, C Rudolph, R Jongen, A De Haas, A Oortwijn, S Vermeire

Journal of Crohn's and Colitis. 2022;16(Supplement_1):i085-i087

Link1

Link2

OP37 Rapidity of symptom improvements during filgotinib induction therapy in patients with Ulcerative Colitis: Post hoc analysis of the phase 2b/3 SELECTION study

S Danese, T Hibi, T E Ritter, J B Dinoso, J Hsieh, C Yun, J Zhang, S Zhao, E V Loftus Jr, G Rogler

Journal of Crohn's and Colitis. 2021;15(Supplement_1):S034-S035

Link1

Link2

Su1565: EFFICACY AND SAFETY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS STRATIFIED BY AGE: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION AND SELECTIONLTE STUDIES

Stefan Schreiber, Edward V. Loftus, Christian Maaser, Silvio Danese, Christine Rudolph, Rob Jongen, Angela de Haas, Alessandra Oortwijn, Séverine Vermeire

Gastroenterology. 2022;162(7):S-632-S-633

Link1 Link2

DOP82 Corticosteroid-free remission of Ulcerative Colitis with filgotinib maintenance therapy: Post hoc analysis of the phase 2b/3 SELECTION study

E Loftus, S Vermeire, B Feagan, C Yun, J Hsieh, X Liu, S Zhao, U Moerch, W J Sandborn, T Hibi

Journal of Crohn's and Colitis. 2021;15(Supplement_1):S112-S113

Link1

Link2

Fr531 EFFICACY AND SAFETY OF FILGOTINIB AS MAINTENANCE THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY

Laurent Peyrin-Biroulet, Edward V. Loftus, Silvio Danese, Séverine Vermeire, William J. Sandborn, Ronald P. Fogel, Sandeep Nijhawan, Radoslaw Kempinski, Rafal Filip, Ihor Hospodarskyy, John McNally, Chohee Yun, Sally Zhao, Xiaopeng Liu, Chantal T. Tasset, Robin Besuyen, Mamoru Watanabe, Stefan Schreiber, Gerhard Rogler, Toshifumi Hibi, Brian G. Feagan

Gastroenterology. 2021;160(6):S-350

Link1 Link2

P427 Efficacy and safety of vedolizumab and adalimumab in Asian adults with moderately to severely active ulcerative colitis: Post-hoc analysis of the VARSITY trial

J S Kim, W K Leung, D C Wu, D Lindner, O Fadeeva, D Demuth

Journal of Crohn's and Colitis. 2021;15(Supplement_1):S431-S432

Link1

Link2

A15 EFFICACY AND SAFETY OF FILGOTINIB AS INDUCTION THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY

B G Feagan, E V Loftus, S Danese, S Vermeire, W J Sandborn, T Ritter, R Mehta, U Seidler, F Seibold, I Beales, H Kim, J McNally, C Yun, S Zhao, X Liu, C Tasset, R Besuyen, M Watanabe, S Schreiber, G Rogler, T Hibi, L Peyrin-Biroulet

Journal of the Canadian Association of Gastroenterology. 2021;4(Supplement_1):18-20

Link1

Link2

648 EFFICACY AND SAFETY OF FILGOTINIB AS INDUCTION THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY

Brian G. Feagan, Edward V. Loftus, Silvio Danese, Séverine Vermeire, William J. Sandborn, Timothy E. Ritter, Rajiv Mehta, Ursula Seidler, Frank Seibold, Ian Beales, Hyo Jong Kim, John McNally, Chohee Yun, Sally Zhao, Xiaopeng Liu, Chantal T. Tasset, Robin Besuyen, Mamoru Watanabe, Stefan Schreiber, Gerhard Rogler, Toshifumi Hibi, Laurent Peyrin-Biroulet

Gastroenterology. 2021;160(6):S-125

Link1 Link2